British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.

Oxford/AstraZeneca jab fails to prevent coronavirus from South African strain: Study

oxfordastrazeneca

Oxford/astrazeneca, News on Oxford/astrazeneca, stories on Oxford/astrazeneca, articles on Oxford/astrazeneca, Oxford/astrazeneca stories at Wion, Oxford/astrazeneca news, Oxford/astrazeneca latest news